6TK-14699-91570

2 vaccinations 9 coded responses 22 check-ins 9 free-text entries 4 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 493 / MI
Registered: 2020-12-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Registered in v-safe
2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-22
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2020-12-28
Survey response — days 1–6 daily, dose 1
MedDRA: Blood glucose increased — Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activities

Free text: Blood glucose won't come down from the 300's regardless the amount of insulin I inject

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-28
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-29
Survey response — day 7, dose 1
MedDRA: Blood glucose increased, Blood insulin increased — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Free text: Elevated blood glucose without ketones, I'm currently giving 150% of my normal insulin dose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-29
Report sent to call center — day 7, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Elevated blood glucose

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Blood glucose increased, Diabetes mellitus, Pre-existing disease — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Elevated blood sugars/insulin resistance (Type 1 diabetes with CGM)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Blood glucose increased, Reaction to previous exposure to any vaccine, Therapy change — Feeling: Good · Headache

Free text: Same as the first dose, had elevated blood sugars for 5 days after and required double my normal dosing to keep it below 200.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-11
Survey response — day 28, dose 2
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Extreme fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-15
Survey response — 3 months, dose 2
MedDRA: Cough, Fatigue, Pain, Rhinorrhoea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Worsening Cough, runny nose, body aches, fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Survey response — 6 months, dose 2
MedDRA: Chest pain, Dyspnoea, Pain, Spinal pain, Wheezing — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Increasing shortness of breath/wheezing, tearing pain substeral and along my thoracic spine, all over body aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-13
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-20
Call 1 — Left Voicemail
2022-01-14
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Diagnosed with Covid on Oct 4, 2021

MedDRA releases: 2024-11 · check-in free text available
2022-01-14
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2022-01-18
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Call center

4 call center cases

2 successful · 2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-28

Systemic reaction (other): Blood glucose won't come down from the 300's regardless the amount of insulin I inject

Release 1 — day 7, dose 1

2020-12-29

Systemic reaction (other): Elevated blood glucose without ketones, I'm currently giving 150% of my normal insulin dose

Release 1 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Elevated blood glucose

Release 2 — days 1–6 daily, dose 2

2021-01-15

Systemic reaction (other): Elevated blood sugars/insulin resistance (Type 1 diabetes with CGM)

2021-01-17

Systemic reaction (other): Same as the first dose, had elevated blood sugars for 5 days after and required double my normal dosing to keep it below 200.

Release 4 — day 28, dose 2

2021-02-11

Symptoms: Extreme fatigue

Release 7 — 3 months, dose 2

2021-04-15

Symptoms: Worsening Cough, runny nose, body aches, fatigue

Release 9 — 6 months, dose 2

2021-07-13

Symptoms: Increasing shortness of breath/wheezing, tearing pain substeral and along my thoracic spine, all over body aches

Release 10 — 12 months, dose 2

2022-01-14

Symptoms: Diagnosed with Covid on Oct 4, 2021

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Chest pain	✓	✓	✓
SD	Cough	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Rhinorrhoea	✓	✓	✓
SD	Spinal pain	✓	✓	✓
SD	Wheezing	✓	✓	✓
SRO	Blood glucose increased	✓	✓	✓
SRO	Blood insulin increased	✓	✓	✓
SRO	Diabetes mellitus	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Reaction to previous exposure to any vaccine	✓	✓	✓
SRO	Therapy change	○	✓	○

✓ active code · ○ coded but marked inactive · blank = not in that release